icon
沙特阿拉伯王国政府所属的官方政府网站。
icon 周四 25 6月 2026
icon
沙特官方政府网站的域名以下列后缀结尾 gov.sa

沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。

icon
政府网站使用以下协议。 HTTPS 用于加密和安全。

沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。

icon
在数字政府管理局注册,编号:
20250831619
建议

Impact on glycaemic control of the intensification of insulin therapy proposed by ADA/EASD guidelines with insulin glargine as pasal insulin plus a single daily dose of insulin glulisine at main meal : Basal plus strategy in real life

Impact on glycaemic control of the intensification of insulin therapy proposed by ADA/EASD guidelines with insulin glargine as pasal insulin plus a single daily dose of insulin glulisine at main meal : Basal plus strategy in real life

icon 2020-07-04
عنوان الدراسة
Impact on glycaemic control of the intensification of insulin therapy proposed by ADA/EASD guidelines with insulin glargine as pasal insulin plus a single daily dose of insulin glulisine at main meal : Basal plus strategy in real life
داعم الدراسة
Sanofi
دواء الدراسة
Lantus®/Apidra®
رقم بروتوكول الدراسة
APIDR_L_05185
حالة الدراسة
Ongoing
موقع الدراسة
King Abdulaziz University Hospital (Jeddah), Armed Forces Hospital (Taif)
مرحلة الدراسة
4